TCR2 Therapeutics Inc (TCRR)

TCR2 Therapeutics Financial Statements


TCR2 Therapeutics Financial Overview

TCR2 Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.987; its P/E ratio is -0.58; TCR2 Therapeutics is scheduled to report earnings on November 16, 2022, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -31.77M$ -29.20M$ -27.62M$ -26.24M$ -24.29M
EBITDA$ -31.07M$ -28.50M$ -26.77M$ -25.47M$ -23.60M
Net Income Common Stockholders$ -31.60M$ -29.12M$ -27.74M$ -26.24M$ -24.31M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 206.24M$ 227.99M$ 232.19M$ 246.72M$ 265.59M
Total Assets$ 308.04M$ 323.25M$ 323.37M$ 346.72M$ 368.14M
Total Debt$ 2.11M$ 26.36M$ 27.12M$ 27.64M$ 51.94M
Net Debt$ -204.12M$ -201.62M$ -205.07M$ -219.08M$ -213.65M
Total Liabilities$ 81.78M$ 67.93M$ 41.89M$ 40.45M$ 39.25M
Stockholders Equity$ 226.26M$ 236.55M$ 252.36M$ 255.32M$ 281.48M
Cash Flow
Free Cash Flow$ -25.74M$ -33.11M$ -30.07M$ -21.73M$ -15.84M
Operating Cash Flow$ -19.53M$ -31.13M$ -23.28M$ -19.38M$ -15.02M
Investing Cash Flow$ -10.33M$ -117.37M$ -16.78M$ 32.76M$ 45.41M
Financing Cash Flow$ -47.00K$ 59.00K$ 131.00K$ 343.00K$ 122.00K
Currency in USD

TCR2 Therapeutics Earnings and Revenue History

TCR2 Therapeutics Debt to Assets

TCR2 Therapeutics Cash Flow

TCR2 Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis